Orthopediatrics CORP Form 4 insider transactions

David R. Pelizzon, a Director at Orthopediatrics Corp., has acquired 11,436 shares of common stock.

Bryan W. Hughes, a Director at Orthopediatrics Corp., acquired 11,436 shares of common stock on June 9, 2026.

Orthopediatrics Corp Director Kelly Laine Fischer acquired 11,436 shares of common stock on June 9, 2026, as reported in a Form 4 filing.

Samuel D. Riccitelli, a Director at Orthopediatrics Corp., acquired 11,436 shares of common stock on June 9, 2026.

Orthopediatrics Corp. Director Harold Ruf reported a transaction involving common stock on June 9, 2026.

David R. Bailey, President and CEO of Orthopediatrics Corp., acquired 119,140 shares of common stock on June 9, 2026.

Orthopediatrics Corp. Director Jimmy Duane McDonald acquired 11,436 shares of common stock on June 9, 2026, as reported in a Form 4 filing.

Marie C. Infante (Reynolds), a Director at Orthopediatrics Corp., acquired 11,436 shares of common stock on June 9, 2026.

Mark C. Throdahl, a Director at Orthopediatrics Corp., reported the acquisition of 11,436 common shares on June 9, 2026.

Orthopediatrics Corp. Director George Sinclair Mitchell acquired 11,436 shares of common stock on June 9, 2026, increasing his direct beneficial ownership.

Daniel J. Gerritzen, General Counsel and Secretary of OrthoPediatrics Corp, reported a gift of 2,479 common shares.

Joseph W. Hauser, President of Trauma & Def. Correction at ORTHOPEDIATRICS CORP, reported acquiring 65,700 shares and selling 8,596 shares to cover tax obligations.

ORTHOPEDIATRICS Corp. COO and CFO Fred Hite reported the acquisition of 77,405 shares and the sale of 12,993 shares to cover tax obligations, as part of a pre-planned transaction.

ORTHOPEDIATRICS CORP's President and CEO, David R. Bailey, sold 19,535 common shares at $17.25 to cover tax obligations from restricted stock vesting.

Orthopediatrics' President of Scoliosis, Gregory A. Odle, sold 8,433 shares of common stock to cover tax withholding obligations following the vesting of restricted shares.

Orthopediatrics General Counsel Daniel J. Gerritzen reported an acquisition of shares followed by a sale to cover tax withholding obligations.

David R. Bailey, President and CEO of OrthoPediatrics Corp, reported gifting 1,600 shares of common stock on December 29, 2025.

ORTHOPEDIATRICS Corp. director Kelly Laine Fischer was granted 4,345 shares of common stock as part of her compensation for service.

OrthoPediatrics' COO and CFO, Fred Hite, purchased 5,076 shares but disgorged $27,664.20 due to a short-swing profit violation.

Orthopediatrics Corp. Director Bryan W. Hughes has acquired 8,401 shares of common stock at a price of $0, increasing his total beneficial ownership to 21,227 shares, including restricted stock awards.

ORTHOPEDIATRICS Corp. Director Marie C. Infante (Reynolds) reported the acquisition of 8,401 shares of common stock on May 23, 2025, increasing her total beneficial ownership to 19,766 shares.

Orthopediatrics Corp. Director Harold Ruf has increased his beneficial ownership in the company by receiving 8,401 shares of common stock as a restricted stock award.

Orthopediatrics Corp. Director Terry D. Schlotterback reported the acquisition of 8,401 shares of common stock, increasing his direct beneficial ownership to 26,619 shares, including restricted stock awards.

ORTHOPEDIATRICS Corp. Director Jimmy Duane McDonald acquired 8,401 shares of common stock on May 23, 2025, increasing his direct beneficial ownership to 13,132 shares.

George Sinclair Mitchell Dyer, a Director and 10% Owner of ORTHOPEDIATRICS CORP, acquired 8,401 shares of common stock on May 23, 2025, increasing his total beneficial ownership to 13,132 shares.

ORTHOPEDIATRICS Corp. Director and 10% Owner David R. Pelizzon acquired 8,401 shares of common stock on May 23, 2025, increasing his direct beneficial ownership to 32,948 shares.

Orthopediatrics Corp. Director Samuel D. Riccitelli has increased his beneficial ownership in the company by acquiring 8,401 shares of common stock through a restricted stock award on May 23, 2025.

Orthopediatrics Corp. Director Mark C. Throdahl has acquired 8,401 shares of common stock, increasing his direct beneficial ownership to 167,881 shares, including restricted stock awards.

Daniel J. Gerritzen, General Counsel and Secretary of Orthopediatrics Corp., sold shares to cover tax withholding obligations upon the vesting of restricted shares.

David R. Bailey, CEO of Orthopediatrics Corp, reports acquisition and disposal of company stock, including sales to cover tax obligations.